BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

722 related articles for article (PubMed ID: 16894293)

  • 1. Signal transduction targets in Kaposi's sarcoma.
    Sullivan R; Dezube BJ; Koon HB
    Curr Opin Oncol; 2006 Sep; 18(5):456-62. PubMed ID: 16894293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging targets and novel strategies in the treatment of AIDS-related Kaposi's sarcoma: bidirectional translational science.
    Dezube BJ; Sullivan R; Koon HB
    J Cell Physiol; 2006 Dec; 209(3):659-62. PubMed ID: 17001705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator.
    Bais C; Santomasso B; Coso O; Arvanitakis L; Raaka EG; Gutkind JS; Asch AS; Cesarman E; Gershengorn MC; Mesri EA
    Nature; 1998 Jan; 391(6662):86-9. PubMed ID: 9422510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aetiology of Kaposi's sarcoma: current understanding and implications for therapy.
    Boshoff C; Weiss RA
    Mol Med Today; 1997 Nov; 3(11):488-94. PubMed ID: 9430784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transformation of primary human endothelial cells by Kaposi's sarcoma-associated herpesvirus.
    Flore O; Rafii S; Ely S; O'Leary JJ; Hyjek EM; Cesarman E
    Nature; 1998 Aug; 394(6693):588-92. PubMed ID: 9707121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunological and inflammatory features of Kaposi's sarcoma and other Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8-associated neoplasias.
    Riva G; Barozzi P; Torelli G; Luppi M
    AIDS Rev; 2010; 12(1):40-51. PubMed ID: 20216909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kaposi's sarcoma-associated herpesvirus viral IFN regulatory factor 1 inhibits transforming growth factor-beta signaling.
    Seo T; Park J; Choe J
    Cancer Res; 2005 Mar; 65(5):1738-47. PubMed ID: 15753369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of AIDS-related Kaposi's sarcoma: advances in target discovery and treatment.
    Dezube BJ
    Expert Rev Anticancer Ther; 2002 Apr; 2(2):193-200. PubMed ID: 12113241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monitoring of endogenous interferon-alpha and human herpesvirus 8 in HIV-infected patients with Kaposi's sarcoma.
    Plettenberg A; Albrecht D; Lorenzen T; Meyer T; Arndt R; Stoehr A
    Eur J Med Res; 2002 Jan; 7(1):19-24. PubMed ID: 11827836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The contribution of systems biology and reverse genetics to the understanding of Kaposi's sarcoma-associated herpesvirus pathogenesis in endothelial cells.
    St├╝rzl M; Konrad A; Alkharsah KR; Jochmann R; Thurau M; Marquardt G; Schulz TF
    Thromb Haemost; 2009 Dec; 102(6):1117-34. PubMed ID: 19967142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kaposi's sarcoma-associated herpesvirus-specific immune reconstitution and antiviral effect of combined HAART/chemotherapy in HIV clade C-infected individuals with Kaposi's sarcoma.
    Bihl F; Mosam A; Henry LN; Chisholm JV; Dollard S; Gumbi P; Cassol E; Page T; Mueller N; Kiepiela P; Martin JN; Coovadia HM; Scadden DT; Brander C
    AIDS; 2007 Jun; 21(10):1245-52. PubMed ID: 17545700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnosis and treatment of HIV-related Kaposi's sarcoma].
    Reyners AK; Sprenger HG; Suurmeijer AJ; van der Graaf WT
    Ned Tijdschr Geneeskd; 2006 Mar; 150(11):589-93. PubMed ID: 16610494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoblastic lymphoma in persons with AIDS-associated Kaposi's sarcoma: a role for Kaposi's sarcoma-associated herpesvirus.
    Engels EA; Pittaluga S; Whitby D; Rabkin C; Aoki Y; Jaffe ES; Goedert JJ
    Mod Pathol; 2003 May; 16(5):424-9. PubMed ID: 12748248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spindle cells and their role in Kaposi's sarcoma.
    Gessain A; Duprez R
    Int J Biochem Cell Biol; 2005 Dec; 37(12):2457-65. PubMed ID: 16188485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabinoid modulation of Kaposi's sarcoma-associated herpesvirus infection and transformation.
    Zhang X; Wang JF; Kunos G; Groopman JE
    Cancer Res; 2007 Aug; 67(15):7230-7. PubMed ID: 17671191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-HIV agent MAP30 modulates the expression profile of viral and cellular genes for proliferation and apoptosis in AIDS-related lymphoma cells infected with Kaposi's sarcoma-associated virus.
    Sun Y; Huang PL; Li JJ; Huang YQ; Zhang L; Huang PL; Lee-Huang S
    Biochem Biophys Res Commun; 2001 Oct; 287(4):983-94. PubMed ID: 11573962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-herpesvirus treatment and risk of Kaposi's sarcoma in HIV infection. Royal Free/Chelsea and Westminster Hospitals Collaborative Group.
    Mocroft A; Youle M; Gazzard B; Morcinek J; Halai R; Phillips AN
    AIDS; 1996 Sep; 10(10):1101-5. PubMed ID: 8874626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kaposi's sarcoma revisited.
    Szajerka T; Jablecki J
    AIDS Rev; 2007; 9(4):230-6. PubMed ID: 18219366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of cell signaling pathways by Kaposi's sarcoma-associated herpesvirus (KSHVHHV-8).
    Damania B
    Cell Biochem Biophys; 2004; 40(3):305-22. PubMed ID: 15211030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Update on Kaposi's sarcoma].
    Morand JJ; Lightburn E; Simon F; Patte JH
    Med Trop (Mars); 2007 Apr; 67(2):123-30. PubMed ID: 17691428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.